- Full physical examination to exclude underlying physical causes (delirium)
- Vital signs: If severely unwell, dehydration/ exhaustion can be potentially fatal
- FBC and glucose
- If evidence of hyperthyroidism on examination (weight loss, tremor, exophthalmos, goitre) consider TFTs if available
- Consider HIV serotesting (HIV can present with secondary mania), U&E, VDRL, and urine drug screen if appropriate.
Bipolar Disorder Management
exp date isn't null, but text field is
Core management
Admission usually required if:
|
- Psychoeducation – give a photocopy of the information leaflet on bipolar and any other appropriate leaflet
- Consider referral to local supportive groups (church, women’s groups, MeHUCA)
- Reduce stress and strengthen social supports
- Promote functioning in daily living activities
- Support carers – give information leaflet
Initial treatment
Commence either a mood stabiliser or an anti-psychotic
- Give Sodium Valproate 400mg nocte. Increase weekly by 200mg until symptoms improved. Usual effective dose 600- 1000mg. Avoid in women of child-bearing age.
or
- Give Carbamazepine 200mg nocte. Increase weekly by 200mg until on 400-600mg. Usual dose 400-600mg daily.
- Use a second-generation antipsychotic (e.g. Risperidone 1 – 2mg) in women of child-bearing age
If psychotic symptoms present also give an anti-psychotic medication such as:
- Chlorpromazine 100-200mg nocte or Haloperidol 2.5mg nocte.
- Diazepam 5mg TDS for a maximum of two weeks may help with reducing agitation and increase sleep in the acute management of mania
Medication tips
- If not improving, ensure that person has been on a typical effective dose of medication for a minimum of four to six weeks before considering switching
- If switching to another medication, begin that medication first and treat with both medications for 2 weeks before tapering off the first medication.
- If response is still poor, consult a specialist
Caution: Avoid Sodium Valproate in women of child-bearing age due to teratogenic effects. If no second-generation antipsychotic available, use Carbamazepine but ensure patient using adequate contraception.
Referral
- Ongoing or worsening symptoms despite adequate treatment for 2 – 4 weeks.
Follow-Up
- For acute mania: Initial follow-up should be as frequent as possible, even daily, until acute symptoms respond to treatment. Once symptoms respond, monthly to quarterly follow-up is recommended.
- For persons not currently in manic or depressed states, follow-up at least every three months.